Publications And Outcomes

The ethical approval process at the Danish (RSD-OUH) and Spanish (UGR) sites is demonstrated by the project descriptions submitted along with applications to their respective Ethics Committees. The project descriptions provide information on the background of the project, its aims, methodology with sub-studies, needs assessment, the anticipated risks, access to patient information, informed consent, impact, funding, the ethics, safety, and security of the project, the members of the research team, and relevant references. Not all sections are described in both the RSD-OUH and the UGR applications.

At UGR ethical approval has been received for the screening solution while approval for the video counseling solution is still pending. At RSD-OUH the screening solution has been implemented throughout the region and thus no ethical approval is needed, and the ethics committee determined that approval was unnecessary for the video counseling intervention.

Application forms and decision letters from the committees are provided in the appendix (these are provided in the local languages).

Intimate partner violence (IPV) during pregnancy is a public health issue with wide-ranging consequences for both the mother and fetus, and interventions are needed. Therefore, the Stop Intimate Partner Violence in Pregnancy (STOP) cohort was established with the overall aim to identify pregnant women exposed to IPV through digital screening and offer women screening positive for IPV a digital supportive intervention.

Intimate partner violence (IPV) during pregnancy, a condition as common as obstetrics conditions like gestational diabetes, is associated with maternal and neonatal complications. Systematic detection of IPV is not well established in antenatal screening probably because the effectiveness of protective interventions has not been evaluated. E-health interventions may be beneficial among mothers exposed to IPV. Prior to performing a full-scale effectiveness trial for such an intervention, a pilot study is required to assess the feasibility of randomising a sufficiently large number of women exposed to IPV during pregnancy. The eIPV trial is a randomised pilot study nested within a cohort of consenting mothers who screen positive for IPV in the first antenatal visit at <12 weeks’ gestation and accept an e-health package (psychological counselling by videoconference) in Spain and Denmark.

The ethical approval process at the Danish (RSD-OUH) and Spanish (UGR) sites is demonstrated by the project descriptions submitted along with applications to their respective Ethics Committees. The project descriptions provide information on the background of the project, its aims, methodology with sub-studies, needs assessment, the anticipated risks, access to patient information, informed consent, impact, funding, the ethics, safety, and security of the project, the members of the research team, and relevant references. Not all sections are described in both the RSD-OUH and the UGR applications.

At UGR ethical approval has been received for the screening solution while approval for the video counseling solution is still pending. At RSD-OUH the screening solution has been implemented throughout the region and thus no ethical approval is needed, and the ethics committee determined that approval was unnecessary for the video counseling intervention.

Application forms and decision letters from the committees are provided in the appendix (these are provided in the local languages).

Intimate partner violence (IPV) during pregnancy is a public health issue with wide-ranging consequences for both the mother and fetus, and interventions are needed. Therefore, the Stop Intimate Partner Violence in Pregnancy (STOP) cohort was established with the overall aim to identify pregnant women exposed to IPV through digital screening and offer women screening positive for IPV a digital supportive intervention.

Intimate partner violence (IPV) during pregnancy, a condition as common as obstetrics conditions like gestational diabetes, is associated with maternal and neonatal complications. Systematic detection of IPV is not well established in antenatal screening probably because the effectiveness of protective interventions has not been evaluated. E-health interventions may be beneficial among mothers exposed to IPV. Prior to performing a full-scale effectiveness trial for such an intervention, a pilot study is required to assess the feasibility of randomising a sufficiently large number of women exposed to IPV during pregnancy. The eIPV trial is a randomised pilot study nested within a cohort of consenting mothers who screen positive for IPV in the first antenatal visit at <12 weeks’ gestation and accept an e-health package (psychological counselling by videoconference) in Spain and Denmark.